Population Health Partners - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2020
Population Health Partners is a capital investment firm that bridges venture capital and private equity, focusing on biotechnology companies addressing prevalent diseases. They typically invest in Series A rounds, aiming to leverage industry-leading technology for efficient product development and disruptive business models. Their goal is to create significant returns by solving health and economic challenges associated with widespread diseases.
Notable portfolio companies include Areteia Therapeutics, which has raised $350 million. The firm prides itself on its strategic and operational approach, offering unique value-add services to portfolio companies. This includes leveraging advanced technology and industry expertise to enhance product development efficiency and foster innovative business models. The team comprises key partners with extensive backgrounds in biotechnology and investment, committed to building transformative companies in the healthcare sector.
Population Health Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
